Test reports of cough syrup linked to Uzbek deaths yet to reach regulator

The official declined to give a timeline for the test reports but said the drug controller has found lapses in documentation and other good manufacturing practices (GMP), and has issued show cause notices to the company while ordering suspension of manufacturing operations. ​​Marion holds an export licence from the UP drug controller to manufacture the Dok-1-Max syrup and tablets.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news